Personal Information
Full Name: Mehmet Akif Durmuş
Academic Title / Position: Specialist Physician (MD)
Current Position: Specialist in Medical Microbiology, Başakşehir Çam and Sakura City Hospital
Education
2006–2012: Düzce University, Faculty of Medicine – Medical Doctor (MD)
2014–2018: Istanbul University, Istanbul Faculty of Medicine – Residency in Medical Microbiology
2018–2020: Istanbul University, Istanbul Faculty of Medicine – Subspecialty Training in Medical Microbiology & Basic Immunology
Professional Experience
2021–Present: Specialist Physician, Department of Medical Microbiology, Başakşehir Çam and Sakura City Hospital
2025–Present: Head of Department (Administrative Director), Department of Medical Microbiology, Başakşehir Çam and Sakura City Hospital
Clinical Research Overview
2017: Investigation of carbapenem resistance in Klebsiella pneumoniae strains using phenotypic and genotypic methods – Principal Investigator
2019: Multicenter prospective study evaluating measles, pneumococcal, and hepatitis B antibody levels before and during biological therapy in previously vaccinated patients – Co-Investigator
2020: Brucella seroprevalence and associated risk factors in patients admitted to a university hospital – Co-Investigator
2020: Antimicrobial resistance profile of Pseudomonas aeruginosa isolated from lower respiratory tract samples – Co-Investigator
2023: UTILISE study – Urinary HSP70 as a diagnostic biomarker for urinary tract infections in children – Co-Investigator
2023: UTILISE study – Urinary soluble TLR4 levels as a predictive marker for urinary tract infections in children – Co-Investigator
2024: Artificial intelligence applications in immunology laboratory: image analysis and classification of indirect immunofluorescence (IIF) images – Principal Investigator
2024: Biofilm formation, anti-quorum sensing activity, and antimicrobial resistance in clinical Corynebacterium isolates – Co-Investigator
2024: UTILISE study – Relationship between urinary HSP70 and congenital anomalies of the kidney and urinary tract – Co-Investigator
2025: Performance evaluation of the Concepta automated ANA detection system in routine clinical samples – Principal Investigator
2025: Comparison of artificial intelligence applications and commercial systems using ANA IIF images – Principal Investigator
2025: Novel β-lactam/β-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae – Co-Investigator
2025: Frequency and clinical significance of the AC-2 pattern variant (AC-30) in immunological testing – Principal Investigator
2025: Evaluation of rational test ordering in autoimmune rheumatologic diseases using ANA IIF and immunoblot correlation – Co-Investigator